NGVT Earnings & Financial Statements
Ingevity Corporation
$70.72
+$0.58(+0.83%)
43
Overall
40
Value
54
Tech
36
Quality
Market Cap
$2.41B
Volume
3.69K
52W Range
$45.85 - $79.29
Target Price
$86.75
NGVT earnings and financial statements: Ingevity Corporation's income statement, balance sheet and cash flow statement, annual and quarterly.
NGVT Annual Financial Statements
| Fiscal year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Revenue | $1.17B | $1.20B | $1.69B | $1.67B | $1.39B |
| Cost of revenue | $706.10M | $735.30M | $1.22B | $1.10B | $878.70M |
| Operating income | $236.90M | $274.30M | $247.10M | $336.00M | $306.60M |
| EBITDA | $25.80M | -$243.30M | $206.00M | $440.20M | $324.40M |
| Net income | -$167.10M | -$430.30M | -$5.40M | $211.60M | $118.10M |
| EPS (diluted) | $-4.61 | $-11.85 | $-0.15 | $5.50 | $2.95 |
| Fiscal year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Total assets | $1.65B | $2.02B | $2.62B | $2.74B | $2.47B |
| Total liabilities | $1.62B | $1.83B | $1.99B | $2.04B | $1.80B |
| Shareholders’ equity | $29.70M | $195.20M | $631.40M | $698.30M | $673.80M |
| Cash and equivalents | $78.10M | $68.00M | $95.90M | $76.70M | $275.40M |
| Long-term debt | $1.18B | $1.37B | $1.43B | $1.51B | $1.29B |
| Fiscal year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Operating cash flow | $331.20M | $128.60M | $205.10M | $313.40M | $293.30M |
| Capital expenditure | -$54.10M | -$77.60M | -$109.80M | -$142.50M | -$103.80M |
| Free cash flow | $273.50M | $51.00M | $95.30M | $170.90M | $189.50M |
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | NGVT | $70.72 | +0.8% | 3.69K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |